Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
201.50    7.50 (3.87%)
Bid:
194.00
Ask:
209.00
Spread: 15.00 (7.732%)
Market Cap: £82.54m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Form 8.3 - Vipera Plc

5 Apr 2018 11:11

Miton Asset Management Limited - Form 8.3 - Vipera Plc

Miton Asset Management Limited - Form 8.3 - Vipera Plc

PR Newswire

London, April 5

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:LF MITON UK SMALLER COMPANIES FUND
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. MITON GROUP PLC
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree VIPERA PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 04/04/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 4,555,556 1.42
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 4,555,556 1.42

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 05/04/2018
Contact name: GEORGE LATIMER-BUTER
Telephone number: 0203 714 1486

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
20th Dec 20247:00 amRNSTransaction in Own Shares
26th Nov 202411:29 amRNSHalf-year Report - Replacement
26th Nov 20247:00 amRNSHalf-year Report
25th Nov 20245:14 pmRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20245:19 pmRNSTransaction in Own Shares
18th Nov 20244:57 pmRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20245:05 pmRNSTransaction in Own Shares
12th Nov 20245:49 pmRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20245:13 pmRNSTransaction in Own Shares
15th Oct 20245:21 pmRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20244:55 pmRNSTransaction in Own Shares
7th Oct 20245:18 pmRNSTransaction in Own Shares
3rd Oct 202410:31 amRNSStatement re MAR
3rd Oct 202410:08 amRNSPortfolio Update and Half Year End Valuation
18th Sep 20249:38 amRNSDividend Declaration
9th Sep 20247:00 amRNSChange of AIFM
23rd Jul 202411:00 amRNSDirector/PDMR Shareholding
17th Jul 20243:22 pmRNSDirectorate Change
11th Jul 20241:13 pmRNSResult of AGM
20th Jun 20245:37 pmRNSTransaction in Own Shares
12th Jun 20247:00 amRNSAnnual Financial Report
29th Apr 20244:58 pmRNSTransaction in Own Shares
25th Apr 20245:01 pmRNSTransaction in Own Shares
24th Apr 20245:24 pmRNSTransaction in Own Shares - Replacement
24th Apr 20245:11 pmRNSTransaction in Own Shares
23rd Apr 20245:16 pmRNSTransaction in Own Shares
18th Apr 20244:56 pmRNSTransaction in Own Shares
15th Apr 20245:03 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20245:13 pmRNSTransaction in Own Shares
4th Apr 20244:59 pmRNSTransaction in Own Shares
4th Apr 202411:39 amRNSStatement re MAR
2nd Apr 20247:00 amRNSAcquisitions and Year End Portfolio Valuation
19th Mar 20245:01 pmRNSTransaction in Own Shares
18th Mar 20244:49 pmRNSTransaction in Own Shares
14th Mar 20244:54 pmRNSTransaction in Own Shares
11th Mar 20245:06 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20244:49 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDividend Declaration
6th Feb 20245:01 pmRNSTransaction in Own Shares
22nd Dec 202312:26 pmRNSHolding(s) in Company
21st Dec 20234:30 pmRNSDirector/PDMR Shareholding
20th Dec 202311:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.